Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04099277
What this trial is testing

LY3435151 in Participants With Solid Tumors

Who this might be right for
Solid TumorTriple-negative Breast CancerGastric Adenocarcinoma+6 more
Eli Lilly and Company 2
Early research (Phase 1)Study completedNCT01875601
What this trial is testing

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

Who this might be right for
Solid TumorsBrain TumorsSarcoma+2 more
National Cancer Institute (NCI) 16
Not applicableStudy completedNCT04593277
What this trial is testing

Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

Who this might be right for
Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8+13 more
Fred Hutchinson Cancer Center 549
Testing effectiveness (Phase 2)Study completedNCT00005628
What this trial is testing

Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03213665
What this trial is testing

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Non-Hodgkin Lymphoma+38 more
National Cancer Institute (NCI) 20
Not applicableEnded earlyNCT02005614
What this trial is testing

A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection

Who this might be right for
MelanomaRenal Cell CarcinomaSarcoma+5 more
Yale University 39
Testing effectiveness (Phase 2)Study completedNCT01459484
What this trial is testing

ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma

Who this might be right for
Osteosarcoma
Italian Sarcoma Group 225
Not applicableActive Not RecruitingNCT06612671
What this trial is testing

Treatment Outcomes of Retroperitoneal Sarcoma

Who this might be right for
Retroperitoneal Sarcoma
Taichung Veterans General Hospital 150
Very early researchStudy completedNCT06273852
What this trial is testing

The Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaSoft Tissue Sarcoma AdultTriple Negative Breast Cancer
Pure Biologics S.A. 8
Testing effectiveness (Phase 2)Study completedNCT02727387
What this trial is testing

Protocol for the Treatment of Metastatic Ewing Sarcoma

Who this might be right for
Ewing's Sarcoma (ES)
Italian Sarcoma Group 155
Early research (Phase 1)Study completedNCT00077454
What this trial is testing

Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Previously Treated Childhood RhabdomyosarcomaRecurrent Childhood Brain TumorRecurrent Childhood Cerebellar Astrocytoma+9 more
National Cancer Institute (NCI) 95
Testing effectiveness (Phase 2)Study completedNCT03449901
What this trial is testing

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer

Who this might be right for
Soft Tissue Sarcoma
Washington University School of Medicine 98
Testing effectiveness (Phase 2)UnknownNCT04699214
What this trial is testing

Endostar Combined With AI Regimen Compared With AI in Adjuvant Treatment

Who this might be right for
Other Disorders of Soft Tissues
Yong Chen 210
Testing effectiveness (Phase 2)Study completedNCT01532687
What this trial is testing

Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+16 more
OHSU Knight Cancer Institute 54
Testing effectiveness (Phase 2)UnknownNCT00980304
What this trial is testing

R Retreatment in 1st Relapsed DLBCL

Who this might be right for
Lymphomas
Shanghai Jiao Tong University School of Medicine
Not applicableLooking for participantsNCT04224064
What this trial is testing

Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas

Who this might be right for
LiposarcomaAtypical Lipomatous Tumor
Institut du Cancer de Montpellier - Val d'Aurelle 158
Testing effectiveness (Phase 2)Active Not RecruitingNCT05726864
What this trial is testing

ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerKRAS G12D+11 more
Elicio Therapeutics 158
Not applicableStudy completedNCT06171945
What this trial is testing

Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors

Who this might be right for
CancerPhysical ActivityCancer Survivorship+2 more
UNC Lineberger Comprehensive Cancer Center 63
Testing effectiveness (Phase 2)Study completedNCT00379145
What this trial is testing

Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus

Who this might be right for
Sarcoma
Gynecologic Oncology Group 20
Testing effectiveness (Phase 2)Study completedNCT02116777
What this trial is testing

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies

Who this might be right for
Adult Solid NeoplasmChildhood Solid NeoplasmRecurrent Childhood Central Nervous System Neoplasm+3 more
National Cancer Institute (NCI) 40
Next Page